Learn More
STUDY DESIGN AND OBJECTIVE Systemic review of double-blind, placebo-controlled, randomized controlled trials (RCTs) and meta-analyses of medication efficacy in the treatment of patients diagnosed with dementia and experiencing neuropsychiatric symptoms(hallucinations, delusions, agitation, aggression, combativeness, wandering). EXCLUSION CRITERIA Studies(More)
Alzheimer disease follows a pattern of gradual cognitive, behavioral, and functional decline. Other causes of dementia have overlapping presentations, but with important differences. Most patients with mild to moderate dementia should be treated with cholinesterase inhibitors to temporarily stabilize symptoms and delay clinically important end points.(More)
OBJECTIVE This guideline provides evidence-based recommendations on managing hoarseness (dysphonia), defined as a disorder characterized by altered vocal quality, pitch, loudness, or vocal effort that impairs communication or reduces voice-related quality of life (QOL). Hoarseness affects nearly one-third of the population at some point in their lives. This(More)
Every fragility fracture represents a missed opportunity. While in the past clinicians had to wait for fracture to diagnose osteoporosis, we now have the means to diagnose and treat before the first fracture. And yet, today, osteoporosis causes more than 2 million fragility fractures annually. In 2005, it was responsible for some 297,000 hip fractures,(More)
Disclaimer: Osteoporosis: Clinical Updates is published by the National Osteoporosis Foundation (NOF).The views and observations presented in Osteoporosis: Clinical Updates are not those of the authors/editors and do not reflect those of the funders or producers of this publication. Readers are urged to consult current prescribing and clinical practice(More)
Disclaimer: Osteoporosis: Clinical Updates is published by the National Osteoporosis Foundation (NOF).The views and observations presented in Osteoporosis: Clinical Updates are not those of the authors/editors and do not reflect those of the funders or producers of this publication. Readers are urged to consult current prescribing and clinical practice(More)
Health care professionals suffer from information overload and struggle to filter evidence relevant to their field. There is a need for solution that facilitates filtering and delivery of information specifically tailored to the needs of researchers and practitioners, and provides an opportunity to efficiently critique and share evidence- based articles.(More)
Obesity is a public health issue of epidemic proportions, ranked the number-one threat to American health by the CDC since 2004. One third of American adults are obese (BMI ≥ 30 kg/m2) and 68% are either overweight or obese (BMI ≥ 25 kg/m 2). 1 Although overall obesity rates have leveled off in the U.S., the rate of severe obesity (BMI ≥40 kg/m 2) continues(More)
Great strides have been made in the diagnosis and treatment of osteoporosis and in prevention of osteoporosis-related fractures. Effective methods for measuring bone density and estimating fracture risk have given primary care providers tools to assess and follow patient bone health and response to treatment. First-generation FDA-approved bisphosphonates(More)
  • 1